middle.news
INOVIQ Raises $9.5M to Fast-Track Ovarian Cancer Test and CAR-Exosome Therapies
9:07am on Wednesday 29th of October, 2025 AEDT
•
Healthcare
Read Story
INOVIQ Raises $9.5M to Fast-Track Ovarian Cancer Test and CAR-Exosome Therapies
9:07am on Wednesday 29th of October, 2025 AEDT
Key Points
Exclusive worldwide licence secured for ovarian cancer exosomal biomarker
CAR-NK-exosomes show potent tumour-killing activity against triple negative breast cancer
Peer-reviewed publication validates CAR-T-exosome efficacy and scalable manufacturing
$9.5 million placement completed with $5 million cornerstone investor from Hong Kong
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE